[DMAC] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[DMAC] DiaMedica Therapeutics Inc.
Announcement Date
13-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 0.13%
YoY- -46.16%
Quarter Report
DMAC's Result
DMAC's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 0 76 0 0 0 504 -
PBT -6,267 -4,464 -3,052 -3,443 -3,191 -2,436 -471 53.87%
Tax 7 -7 7 7 2 12 57 -29.47%
NP -6,274 -4,471 -3,059 -3,450 -3,193 -2,448 -529 50.95%
Tax Rate - - - - - - - -
Total Cost 6,274 4,471 3,135 3,450 3,193 2,448 1,032 35.05%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 0.00 -4,025.00 0.00 0.00 0.00 -104.95 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.15 -0.12 -0.12 -0.18 -0.19 -0.20 -0.07 13.53%
EPS Diluted -0.15 -0.12 -0.12 -0.18 -0.19 -0.20 -0.07 13.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.